Medical College of Wisconsin
CTSI
Cores Search
Research Informatics
REDCap
Faculty Collaboration Database
Profiles for MCW, MU, MSOE, UWM, BCW, CW, Froedtert, and VA Faculty
Email:
Pass:
Lost Password? / First Time Login Help
Home
About
Search
Contact
Tips
Tutorials
Browse MESH
Alexandra M. Harrington MD
Professor
Institution:
Medical College of Wisconsin
Department:
Pathology
Division:
Administration
Member of the Cancer Center
Member of the Kern Institute
Send Message
Request Meeting
View Curriculum Vitae
Publications (49)
How I Diagnose Mature T-Cell Proliferations by Flow Cytometry.
(Kroft SH, Harrington AM)
Am J Clin Pathol
2022 Oct 06;158(4):456-471 PMID: 35929508 SCOPUS ID: 2-s2.0-85139572975 08/06/2022
Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome.
(Corrao K, Rezwan S, Atallah E, Michaelis LC, Runaas L, Harrington AM, Abedin S)
Leuk Res Rep
2022;17:100329 PMID: 35651540 PMCID: PMC9150024 SCOPUS ID: 2-s2.0-85131561638 06/03/2022
1 Citation
Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse.
(Dhakal B, Sharma S, Balcioglu M, Shchegrova S, Malhotra M, Zimmermann B, Billings PR, Harrington A, Sethi H, Aleshin A, Hari PN)
Front Oncol
2022;12:786451 PMID: 35186734 PMCID: PMC8848740 SCOPUS ID: 2-s2.0-85124893548 02/22/2022
2 Citations
Hemophagocytosis in cerebrospinal fluid after CAR T-cell therapy.
(Shah NN, Harrington AM)
Blood
2022 Feb 17;139(7):1116 PMID: 35175320 SCOPUS ID: 2-s2.0-85124777621 02/18/2022
Post-transplant primary cutaneous peripheral T-cell lymphoma not otherwise specified in a pediatric patient.
(Cardwell LA, Majerowski J, Chiu YE, Harrington AM, Sokumbi O)
J Cutan Pathol
2021 May;48(5):706-712 PMID: 33476057 SCOPUS ID: 2-s2.0-85102302501 01/22/2021
1 Citation
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia.
(Mushtaq MU, Harrington AM, Chaudhary SG, Michaelis LC, Carlson KB, Abedin S, Runass L, Callander NS, Fallon MJ, Juckett M, Hall AC, Hematti P, Mattison RJ, Atallah EL, Guru Murthy GS)
Leuk Lymphoma
2021 Jan;62(1):158-166 PMID: 32951486 SCOPUS ID: 2-s2.0-85091139710 09/22/2020
7 Citations
Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them.
(Chhabra S, Szabo A, Glisch C, George G, Narra RK, Harrington A, Jerkins JH, D'Souza A, Dhakal B, Pasquini MC, Hamadani M, Hari PN)
Biol Blood Marrow Transplant
2020 Jul;26(7):1288-1297 PMID: 32135202 SCOPUS ID: 2-s2.0-85083636589 03/07/2020
8 Citations
Simple Laboratory Test Utilization Interventions to Reduce Inappropriate Specialty Coagulation Testing.
(Huang H, Cunningham AM, Harrington AM)
Am J Clin Pathol
2020 Jan 02;153(2):181-189 PMID: 31602457 SCOPUS ID: 2-s2.0-85077403173 10/12/2019
2 Citations
Ancillary Studies in the Diagnostic Evaluation of Large B-Cell Lymphoma.
(Cunningham AM, Harrington AM)
Arch Pathol Lab Med
2019 Dec;143(12):1464-1471 PMID: 31584842 SCOPUS ID: 2-s2.0-85075813941 10/05/2019
1 Citation
Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review.
(Ronen S, Kroft SH, Olteanu H, Hosking PR, Harrington AM)
Int J Lab Hematol
2019 Feb;41(1):69-79 PMID: 30216684 SCOPUS ID: 2-s2.0-85053471510 09/15/2018
5 Citations
Daratumumab in Primary Effusion Lymphoma.
(Shah NN, Singavi AK, Harrington A)
N Engl J Med
2018 Aug 16;379(7):689-690 PMID: 30110586 SCOPUS ID: 2-s2.0-85051817119 08/16/2018
26 Citations
Flow Cytometry of B-Cell Neoplasms.
(Kroft SH, Harrington AM)
Clin Lab Med
2017 Dec;37(4):697-723 PMID: 29128065 SCOPUS ID: 2-s2.0-85028626763 11/13/2017
12 Citations
CD30 Expression in Monomorphic Posttransplant Lymphoproliferative Disorder, Diffuse Large B-Cell Lymphoma Correlates With Greater Regulatory T-Cell Infiltration.
(Hartley C, Vaughan JW, Jarzembowski J, Kroft SH, Hosking P, Harrington AM, Olteanu H)
Am J Clin Pathol
2017 Nov 20;148(6):485-493 PMID: 29126177 SCOPUS ID: 2-s2.0-85038129680 11/11/2017
9 Citations
Evaluation of CD43 expression in non-hematopoietic malignancies.
(Batdorf BH, Kroft SH, Hosking PR, Harrington AM, Mackinnon AC, Olteanu H)
Ann Diagn Pathol
2017 Aug;29:23-27 PMID: 28807337 SCOPUS ID: 2-s2.0-85018328698 08/16/2017
8 Citations
Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysis.
(Chang JC, Harrington AM, Olteanu H, VanTuinen P, Kroft SH)
Ann Diagn Pathol
2016 Dec;25:15-19 PMID: 27806839 SCOPUS ID: 2-s2.0-84985930576 11/04/2016
3 Citations
Extracavitary primary effusion lymphoma associated with hemophagocytic lymphohistiocytosis.
(Epperla N, Harrington AM, Hemauer K, Shah NN)
Am J Hematol
2016 Nov;91(11):1161-1164 PMID: 27414752 SCOPUS ID: 2-s2.0-84989227504 10/21/2016
5 Citations
Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry: A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes.
(Harrington AM, Schelling LA, Ordobazari A, Olteanu H, Hosking PR, Kroft SH)
Am J Clin Pathol
2016 Aug;146(2):170-81 PMID: 27413139 SCOPUS ID: 2-s2.0-85013701127 07/15/2016
12 Citations
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival.
(Dhakal B, D'Souza A, Martens M, Kapke J, Harrington AM, Pasquini M, Saber W, Drobyski WR, Zhang MJ, Hamadani M, Hari PN)
Clin Lymphoma Myeloma Leuk
2016 Jul;16(7):379-86 PMID: 27160644 SCOPUS ID: 2-s2.0-84965053091 05/11/2016
15 Citations
Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.
(Li H, Hasserjian RP, Kroft SH, Harrington AM, Wheaton SE, Pildain A, Ewalt MD, Gratzinger D, Hosking P, Olteanu H)
Am J Clin Pathol
2016 Apr;145(4):538-51 PMID: 27124944 SCOPUS ID: 2-s2.0-84981272203 04/29/2016
18 Citations
Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer.
(Nelson AA, Harrington AM, Kroft S, Dahar MA, Hamadani M, Dhakal B)
Bone Marrow Transplant
2016 Feb;51(2):300-2 PMID: 26457913 SCOPUS ID: 2-s2.0-84956921726 10/13/2015
26 Citations
Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.
(Cogbill CH, Spears MD, Vantuinen P, Harrington AM, Olteanu H, Kroft SH)
Int J Lab Hematol
2015 Dec;37(6):797-808 PMID: 26224420 SCOPUS ID: 2-s2.0-84973454837 08/01/2015
10 Citations
Localized lymph node light chain amyloidosis.
(Dhakal B, Harrington AM, Stadler ME, D'Souza A)
Case Rep Hematol
2015;2015:816565 PMID: 25922771 PMCID: PMC4398934 04/30/2015
Post-transplant lymphoproliferative disorders.
(Singavi AK, Harrington AM, Fenske TS)
Cancer Treat Res
2015;165:305-27 PMID: 25655616 SCOPUS ID: 2-s2.0-84922354492 02/07/2015
67 Citations
Bone marrow
(Kroft SH, Harrington AM, McKenna RW)
Sternberg's Diagnostic Surgical Pathology: Sixth Edition
21 January 2015;1-2 SCOPUS ID: 2-s2.0-84975106811 01/21/2015
Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers.
(Wildes TM, Farrington L, Yeung C, Harrington AM, Foyil KV, Liu J, Kreisel F, Bartlett NL, Fenske TS)
Ther Adv Hematol
2014 Feb;5(1):3-12 PMID: 24490019 PMCID: PMC3891289 SCOPUS ID: 2-s2.0-84993683928 02/04/2014
18 Citations
CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.
(Olteanu H, Harrington AM, Kroft SH)
Am J Clin Pathol
2012 Dec;138(6):867-76 PMID: 23161721 SCOPUS ID: 2-s2.0-84869234870 11/20/2012
9 Citations
Time and temperature stability of T-cell subsets evaluated by a dual-platform method.
(Olteanu H, Schur BC, Harrington AM, Kroft SH)
Am J Blood Res
2012;2(2):128-35 PMID: 22762032 PMCID: PMC3384401 07/05/2012
Immunophenotypic stability of CD200 expression in plasma cell myeloma.
(Olteanu H, Harrington AM, Kroft SH)
Am J Clin Pathol
2012 Jun;137(6):1013-4 PMID: 22586062 SCOPUS ID: 2-s2.0-84863733413 05/16/2012
5 Citations
A dissection of the CD45/side scatter "blast gate".
(Harrington AM, Olteanu H, Kroft SH)
Am J Clin Pathol
2012 May;137(5):800-4 PMID: 22523220 SCOPUS ID: 2-s2.0-84862621107 04/24/2012
22 Citations
Immunophenotypic stability of Sézary cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapy.
(Vaughan J, Harrington AM, Hari PN, Kroft SH, Olteanu H)
Am J Clin Pathol
2012 Mar;137(3):403-11 PMID: 22338052 SCOPUS ID: 2-s2.0-84859238276 02/18/2012
22 Citations
Flow cytometric analysis of surface light chain expression patterns in B-cell lymphomas using monoclonal and polyclonal antibodies.
(Horna P, Olteanu H, Kroft SH, Harrington AM)
Am J Clin Pathol
2011 Dec;136(6):954-9 PMID: 22095382 SCOPUS ID: 2-s2.0-82655171624 11/19/2011
25 Citations
Clinicopathologic analysis of the impact of CD23 expression in plasma cell myeloma with t(11;14)(q13;q32).
(Buonaccorsi JN, Kroft SH, Harrington AM, VanTuinen P, Olteanu H)
Ann Diagn Pathol
2011 Dec;15(6):385-8 PMID: 21724429 SCOPUS ID: 2-s2.0-81155131189 07/05/2011
4 Citations
High prevalence of Dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency.
(Olteanu H, Harrington AM, George B, Hari PN, Bredeson C, Kroft SH)
Bone Marrow Transplant
2012 Mar;47(3):399-403 PMID: 21478917 SCOPUS ID: 2-s2.0-84858075288 04/12/2011
15 Citations
The immunophenotypic stability of plasma cell myeloma by flow cytometry.
(Spears MD, Olteanu H, Kroft SH, Harrington AM)
Int J Lab Hematol
2011 Oct;33(5):483-91 PMID: 21470371 SCOPUS ID: 2-s2.0-80051926755 04/08/2011
10 Citations
Immunophenotypic signatures of benign and dysplastic granulopoiesis by cytomic profiling.
(Finn WG, Harrington AM, Carter KM, Raich R, Kroft SH, Hero AO 3rd)
Cytometry B Clin Cytom
2011 Sep;80(5):282-90 PMID: 21462309 SCOPUS ID: 2-s2.0-80051865146 04/05/2011
8 Citations
The unique immunophenotype of double-hit lymphomas.
(Harrington AM, Olteanu H, Kroft SH, Eshoa C)
Am J Clin Pathol
2011 Apr;135(4):649-50 PMID: 21411790 SCOPUS ID: 2-s2.0-79954607752 03/18/2011
29 Citations
CD200 expression in plasma cell myeloma.
(Olteanu H, Harrington AM, Hari P, Kroft SH)
Br J Haematol
2011 May;153(3):408-11 PMID: 21275968 SCOPUS ID: 2-s2.0-79954419980 02/01/2011
32 Citations
CD23 expression in follicular lymphoma: clinicopathologic correlations.
(Olteanu H, Fenske TS, Harrington AM, Szabo A, He P, Kroft SH)
Am J Clin Pathol
2011 Jan;135(1):46-53 PMID: 21173123 SCOPUS ID: 2-s2.0-79251510889 12/22/2010
29 Citations
Multifocal vulvar smooth muscle tumor with an unusual intravascular growth pattern and multiple local recurrences in a 10-year-old child: a diagnostic dilemma.
(Harrington A, Bell E, Suchi M, Behmaram B, Uyar D)
Pediatr Dev Pathol
2011;14(3):235-9 PMID: 21090988 SCOPUS ID: 2-s2.0-80054051952 11/26/2010
1 Citation
The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders.
(Harrington A, Olteanu H, Kroft S)
Am J Clin Pathol
2010 Nov;134(5):749-61 PMID: 20959658 SCOPUS ID: 2-s2.0-78049510026 10/21/2010
24 Citations
Immunophenotypic stability of T-cell large granular lymphocytic leukaemia by flow cytometry.
(Spears MD, Harrington AM, Kroft SH, Olteanu H)
Br J Haematol
2010 Oct;151(1):97-9 PMID: 20636433 SCOPUS ID: 2-s2.0-77956860709 07/20/2010
5 Citations
Persistent localized bone marrow aplasia after radiotherapy with preserved peripheral counts: a study of 8 cases.
(Harrington AM, Currey A, Olteanu H, Kroft SH)
Ann Diagn Pathol
2010 Jun;14(3):168-72 PMID: 20471561 SCOPUS ID: 2-s2.0-77952107485 05/18/2010
2 Citations
Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia.
(Olteanu H, Harrington AM, Ramirez S, Kroft SH, Hari P)
Br J Haematol
2010 Aug;150(4):480-1 PMID: 20456357 SCOPUS ID: 2-s2.0-77955163811 05/12/2010
3 Citations
Sperm in peritoneal fluid from a man with ascites: a case report.
(Olteanu H, Harrington A, Kroft SH)
Cases J
2009 Nov 12;2:192 PMID: 19946502 PMCID: PMC2783147 SCOPUS ID: 2-s2.0-77953377747 12/01/2009
1 Citation
Utility of CD56 immunohistochemical studies in follow-up of plasma cell myeloma.
(Harrington AM, Hari P, Kroft SH)
Am J Clin Pathol
2009 Jul;132(1):60-6 PMID: 19864234 SCOPUS ID: 2-s2.0-67650471360 10/30/2009
22 Citations
Easy bruising, cataracts, and hearing loss in a 27-year-old female
(Harrington A, Ward PCJ, Kroft SH)
Laboratory Medicine
2008;39(1):20-22 SCOPUS ID: 2-s2.0-62749197627 12/01/2008
Pencil cells and prekeratocytes in iron deficiency anemia.
(Harrington AM, Kroft SH)
Am J Hematol
2008 Dec;83(12):927 PMID: 18932191 SCOPUS ID: 2-s2.0-56749090691 10/22/2008
5 Citations
Iron deficiency anemia, beta-thalassemia minor, and anemia of chronic disease: a morphologic reappraisal.
(Harrington AM, Ward PC, Kroft SH)
Am J Clin Pathol
2008 Mar;129(3):466-71 PMID: 18285271 SCOPUS ID: 2-s2.0-41649083989 02/21/2008
41 Citations
An 18-year-old male with shortness of breath and cough
(Harrington A, Komorowski R, Kroft SH)
Laboratory Medicine
June 2006;37(6):340-342 SCOPUS ID: 2-s2.0-33744460482 01/01/2006
Last update: 04/02/2023